Your browser doesn't support javascript.
loading
Genetic analysis of a SARS-CoV-2 Omicron variant from a Chinese traveller returning from overseas.
Jia, Hongling; Wang, Hui; Cao, Lan; Lai, Zhisheng; Cheng, Zichun; Chen, Qingpei; Liu, Tongzheng; Liu, Xiangyi; Wen, Yanting; Xu, Conghui; Lu, Weizhi; Yang, Guang; Zhou, Deqian; Di, Biao; Gao, Feng; Yang, Zhicong.
Afiliação
  • Jia H; Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Wang H; Department of Medical Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, People's Republic of China.
  • Cao L; Institute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, People's Republic of China.
  • Lai Z; Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Cheng Z; Yuexiu District Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Chen Q; Institute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, People's Republic of China.
  • Liu T; Clinical Data Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Liu X; College of Pharmacy, Jinan University, Guangzhou, People's Republic of China.
  • Wen Y; Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Xu C; Yuexiu District Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Lu W; Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Yang G; Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Zhou D; Department of Pathogen Biology, School of Medicine, Jinan University, Guangzhou, People's Republic of China.
  • Di B; Yuexiu District Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Gao F; Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
  • Yang Z; Institute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou, People's Republic of China.
Emerg Microbes Infect ; 11(1): 306-309, 2022 Dec.
Article em En | MEDLINE | ID: mdl-34983331
Since the SARS-CoV-2 Omicron variant was first reported from South Africa, it has rapidly spread in over 100 countries. Only two cases infected by the Omicron variant were recently identified in China. The one case in Guangzhou has a relatively long incubation time and mild symptoms. Analysis of the complete viral genome sequence shows three missing Omicron unique mutations and one additional mutation in the newly characterized genome. These unique mutations may be related to the clinical presentation in this case.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Africa / Asia Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Africa / Asia Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article